The store will not work correctly when cookies are disabled.
(3,9-Diazaspiro[5.5]undecan-3-yl)(3-(thiophen-2-ylmethoxy)-phenyl)methanone
ID: ALA5202160
PubChem CID: 168292453
Max Phase: Preclinical
Molecular Formula: C21H26N2O2S
Molecular Weight: 370.52
Associated Items:
Names and Identifiers
Canonical SMILES: O=C(c1cccc(OCc2cccs2)c1)N1CCC2(CCNCC2)CC1
Standard InChI: InChI=1S/C21H26N2O2S/c24-20(23-12-8-21(9-13-23)6-10-22-11-7-21)17-3-1-4-18(15-17)25-16-19-5-2-14-26-19/h1-5,14-15,22H,6-13,16H2
Standard InChI Key: ILRNWAYGXRJVHI-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 29 0 0 0 0 0 0 0 0999 V2000
2.8334 -24.1603 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5485 -24.5718 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2606 -24.1642 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2638 -23.3393 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.5488 -22.9236 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8305 -23.3370 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4076 -24.1603 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4076 -24.9875 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.1221 -25.3949 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8367 -24.9875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1221 -23.7403 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9777 -22.9254 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9798 -22.0982 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.6879 -23.3371 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6863 -24.1613 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3981 -24.5730 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1120 -24.1618 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1097 -23.3343 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3973 -22.9263 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8213 -22.9206 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.5353 -23.3299 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2469 -22.9161 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9978 -23.2441 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5467 -22.6307 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1328 -21.9191 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3283 -22.0928 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
1 6 1 0
2 3 1 0
3 4 1 0
4 5 1 0
5 6 1 0
7 8 1 0
7 11 1 0
8 9 1 0
9 10 1 0
10 1 1 0
1 11 1 0
4 12 1 0
12 13 2 0
14 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 14 1 0
12 14 1 0
18 20 1 0
20 21 1 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 26 1 0
26 22 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 370.52 | Molecular Weight (Monoisotopic): 370.1715 | AlogP: 3.93 | #Rotatable Bonds: 4 |
Polar Surface Area: 41.57 | Molecular Species: BASE | HBA: 4 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 10.33 | CX LogP: 3.05 | CX LogD: 0.29 |
Aromatic Rings: 2 | Heavy Atoms: 26 | QED Weighted: 0.89 | Np Likeness Score: -1.54 |
References
1. Bavo F, de-Jong H, Petersen J, Falk-Petersen CB, Löffler R, Sparrow E, Rostrup F, Eliasen JN, Wilhelmsen KS, Barslund K, Bundgaard C, Nielsen B, Kristiansen U, Wellendorph P, Bogdanov Y, Frølund B.. (2021) Structure-Activity Studies of 3,9-Diazaspiro[5.5]undecane-Based γ-Aminobutyric Acid Type A Receptor Antagonists with Immunomodulatory Effect., 64 (24.0): [PMID:34908407] [10.1021/acs.jmedchem.1c00290] |